These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Hyperuricemia and gout]. Gröbner W Dtsch Med Wochenschr; 2015 Oct; 140(21):1615-26. PubMed ID: 26488103 [TBL] [Abstract][Full Text] [Related]
4. Effect of allopurinol on slowing allograft functional decline in kidney transplant recipients. Osadchuk L; Bashir MH; Tangirala B; Marcus RJ; Nashar K; Hussain SM; Sureshkumar KK Exp Clin Transplant; 2014 Jun; 12(3):190-4. PubMed ID: 24907717 [TBL] [Abstract][Full Text] [Related]
5. Lesinurad/allopurinol (Duzallo) for gout-associated hyperuricemia. Med Lett Drugs Ther; 2017 Nov; 59(1533):182-183. PubMed ID: 29125593 [No Abstract] [Full Text] [Related]
6. Managing new-onset gout in pediatric renal transplant recipients: when, how, to what extent. Assadi F J Nephrol; 2013; 26(4):624-8. PubMed ID: 22941874 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of hyperuricemia and gout]. Gröbner W; Walter-Sack I Med Monatsschr Pharm; 2005 May; 28(5):159-64; quiz 165-6. PubMed ID: 15912988 [No Abstract] [Full Text] [Related]
8. Switching from allopurinol to febuxostat: efficacy and safety in the treatment of hyperuricemia in renal transplant recipients. Li Y; Liu M; Zhang X; Lu Y; Meng J Ren Fail; 2019 Nov; 41(1):595-599. PubMed ID: 31267805 [TBL] [Abstract][Full Text] [Related]
9. Management of Gout and Hyperuricemia in CKD. Vargas-Santos AB; Neogi T Am J Kidney Dis; 2017 Sep; 70(3):422-439. PubMed ID: 28456346 [TBL] [Abstract][Full Text] [Related]
10. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia. Huang X; Du H; Gu J; Zhao D; Jiang L; Li X; Zuo X; Liu Y; Li Z; Li X; Zhu P; Li J; Zhang Z; Huang A; Zhang Y; Bao C Int J Rheum Dis; 2014 Jul; 17(6):679-86. PubMed ID: 24467549 [TBL] [Abstract][Full Text] [Related]